Orchard Therapeutics PLC Price Prediction
| ORTXDelisted Stock | USD 16.70 0.00 0.00% |
Oversold Vs Overbought
64
Oversold | Overbought |
Orchard Therapeutics PLC stock price prediction is an act of determining the future value of Orchard Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Orchard Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Orchard Therapeutics and does not consider all of the tangible or intangible factors available from Orchard Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Orchard Therapeutics PLC, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether delisted stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Orchard Therapeutics based on different types of headlines from major news networks to social media. The Orchard stock price prediction module provides an analysis of price elasticity to changes in media outlook on Orchard Therapeutics over a specific investment horizon. Using Orchard Therapeutics hype-based prediction, you can estimate the value of Orchard Therapeutics PLC from the perspective of Orchard Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Orchard Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Orchard Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Orchard because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Orchard Therapeutics after-hype prediction price | USD 16.7 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Orchard |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Orchard Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Orchard Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Orchard Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Orchard Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Orchard Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Orchard Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Orchard Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Orchard Therapeutics' historical news coverage. Orchard Therapeutics' after-hype downside and upside margins for the prediction period are 16.70 and 16.70, respectively. We have considered Orchard Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Orchard Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Orchard Therapeutics PLC is based on 3 months time horizon.
Orchard Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Orchard Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Orchard Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Orchard Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 6 Events / Month | 7 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
16.70 | 16.70 | 0.00 |
|
Orchard Therapeutics Hype Timeline
Orchard Therapeutics PLC is now traded for 16.70. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Orchard is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on Orchard Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 16.70. About 12.0% of the company outstanding shares are owned by corporate insiders. The book value of Orchard Therapeutics was now reported as 3.53. The company recorded a loss per share of 4.1. Orchard Therapeutics PLC had not issued any dividends in recent years. The entity had 1:10 split on the 10th of March 2023. Given the investment horizon of 90 days the next anticipated press release will be in about 6 days. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.Orchard Therapeutics Related Hype Analysis
Having access to credible news sources related to Orchard Therapeutics' direct competition is more important than ever and may enhance your ability to predict Orchard Therapeutics' future price movements. Getting to know how Orchard Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Orchard Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| XFOR | X4 Pharmaceuticals | (0.03) | 9 per month | 4.91 | 0.09 | 10.47 | (9.09) | 40.83 | |
| TERN | Terns Pharmaceuticals | 0.03 | 7 per month | 5.29 | 0 | 8.64 | (8.38) | 27.76 | |
| DAWN | Day One Biopharmaceuticals | 0.38 | 11 per month | 4.33 | 0.07 | 8.19 | (8.71) | 24.09 | |
| PDSB | PDS Biotechnology Corp | 0.18 | 9 per month | 0.00 | (0.1) | 7.76 | (9.16) | 26.33 | |
| INZY | Inozyme PharmaInc | (0.35) | 8 per month | 0.00 | (0.05) | 7.41 | (8.42) | 21.55 | |
| ELDN | Eledon Pharmaceuticals | (0.05) | 4 per month | 4.09 | 0.08 | 8.60 | (6.53) | 35.55 | |
| HOOK | Hookipa Pharma | (0.03) | 10 per month | 2.92 | 0.14 | 9.88 | (5.88) | 24.40 | |
| AMLX | Amylyx Pharmaceuticals | (0.02) | 9 per month | 0.00 | (0.15) | 7.95 | (8.30) | 103.39 | |
| ABOS | Acumen Pharmaceuticals | 0.35 | 9 per month | 3.92 | 0.03 | 7.28 | (5.98) | 23.58 |
Orchard Therapeutics Additional Predictive Modules
Most predictive techniques to examine Orchard price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Orchard using various technical indicators. When you analyze Orchard charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Orchard Therapeutics Predictive Indicators
The successful prediction of Orchard Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Orchard Therapeutics PLC, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Orchard Therapeutics based on analysis of Orchard Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Orchard Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Orchard Therapeutics's related companies. Story Coverage note for Orchard Therapeutics
The number of cover stories for Orchard Therapeutics depends on current market conditions and Orchard Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Orchard Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Orchard Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Orchard Therapeutics Short Properties
Orchard Therapeutics' future price predictability will typically decrease when Orchard Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Orchard Therapeutics PLC often depends not only on the future outlook of the potential Orchard Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Orchard Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 12.8 M | |
| Cash And Short Term Investments | 143.8 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Orchard Stock
If you are still planning to invest in Orchard Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orchard Therapeutics' history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |